InvestorsHub Logo
icon url

marzan

03/27/23 10:47 PM

#580963 RE: marzan #580792

ATL/flipper/doclogic/TDD/senti/iwasadier/ILT/Horseb4ct/all longs, please login to the FDA guidance document Tumor agnostic one D-0286 and please write to FDA as many comments as possible on the need for Tumor Agnostic approval or Mechanism Of Action approval to DcVaxL. See the 10 comments posted there from PFE, MRK, GSK, Novartis and others that the BPs are asking Tumor Agnostic label to their CI therapies like Keytruda. We should do the same for DcVaxL which is far better than the CIs. NWBO LP or LL may not want to post their comment there to avoid the notion of Front Running or so as the Company is in the process of seeking regulatory approval for GBM. There are two methods of posting our comments as that from the investors or public: 1) online and 2) if online posting doesn't work, it says mail it to FDA at the address given like Dr. Beckman did with a Return Receipt.

Let us all flood the site posting our comments with DcVaxL as Tumor Agnostic please. Thanks in advance.